期刊文献+

兔眼增殖性玻璃体视网膜病变模型的建立 被引量:2

Establishment of a Rabbit Model of Proliferative Vitreoretinopathy
下载PDF
导出
摘要 目的探讨兔眼增殖性玻璃体视网膜病变模型的建立方法。方法①体外培养兔眼视网膜色素上皮细胞;②兔眼3组,每组6只,分别在玻璃体内注射0.1 mL的生理盐水、1×106细胞及2×106细胞,在不同时间段进行裂隙灯显微镜、间接检眼镜、眼底照像和B超检查,观察成模情况。结果注射后28 d,生理盐水组成模0眼;1×106细胞组成模5眼,其中Ⅰ级眼1只,Ⅱ级眼3只,Ⅲ级眼1只;2×106细胞组成模6眼,其中Ⅱ级眼2只,Ⅲ级眼4只。结论兔眼玻璃体内注射2×106同种视网膜色素上皮细胞建立增殖性玻璃体视网膜病变模型,符合病变发展规律,而且稳定可靠,成模较快,简单易行。 Objective To establish an animal model of proliferative vitreoretinopathy(PVR) in rabbit eyes. Methods The retinal pigment epithelial (RPE) cells were dissociated from rabbit eyes and cultured. 18 rabbit eyes were divided randomly into 3 groups:0. 1 mL normal saline, 1 × 106 cells (0.1 mL) and 2 × 106 cells (0.1 mL) were injected into the vitreous of 3 groups,respectively. All eyes were examined by slit-lamp biomicroscopy, indirect ophthalmoscopy, fundus color camera and B ultrasonography at different stages. Results On 28 d after ceils injection, 0 PVR eye was found in normal saline group, 5 PVR eyes were found in 1× 10^6 cells group included leye in stage Ⅰ ,3 eyes in stage Ⅱ and 1 eye in stage Ⅲ ,and 6 PVR eyes in 2 × 10^6 cells group included 2 eyes in stage Ⅱ and 4 eyes in stage Ⅲ . Conclusion This PVR model established by injection of 2 × 10^6 homologous RPE cells into rabbit vitreous is consistent with the development course of proliferative vitreoretinopathy. It can be created in a short time, with simplicity, good stablity and reproducibility.
出处 《中国实验动物学报》 CAS CSCD 2008年第6期428-430,I0004,共4页 Acta Laboratorium Animalis Scientia Sinica
关键词 增殖性玻璃体视网膜病变 视网膜色素上皮细胞 动物模型 Proliferative vitreoretinopathy Retinal pigment epithelial cells Rabbit Animal model
  • 相关文献

参考文献9

二级参考文献26

  • 1张阳,盖春柳,徐洪斌,马崇泽,杨英.兔先天性青光眼网络膜血管改变[J].中国实验动物学报,2001,9(1):45-48. 被引量:4
  • 2庞利民 刘克非 等.实验性视网膜脱离动物模型的制备[J].眼科研究,1988,6:15-17.
  • 3Danis AP, Yang Y, Massicotte SJ, et al. Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in dometic pigs[J]. Arch Opthaomol 1993, 111:539 - 543.
  • 4Adamis A, Shima D, Tolention M, et al. Inhibition of VEGF prevent ocular neovascularization in non-human primate[J]. Arch Ophthalmol, 1996, 114:66-71.
  • 5Ferrar N, Houch K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins[J]. Endoc Rev, 1992, 13:18-32.
  • 6Shweiki D. Itin A, Softer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis[J]. Nature, 1992, 359:843-845.
  • 7Pierce EA, Avery R, Foiey E, et al. Vascular endothdial growth factor/vascular permeability factor expression in a mouse model of renal neovascularization[J]. Proc Natl Acad U S A, 1995, 92:905 -909.
  • 8Shima DT. Gougos A, Miner JW, et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis[J]. Invest Ophthalmol Vis Sci, 1996, 37:1334-1340.
  • 9Mangelsehots E, Leys A, Spileers W. Electroretinographic findings versus fluorescein angiographic appearance of the retina in patients with ischaemic and non-ischaemic central retinal vein occlusion[J] .Bull Soc Beige Ophtalmol. 1995, 255:9- 16.
  • 10Wu DZ. The development of clinical visual dectrophysiology [J]Yanke Ophthal Chin, 2001, 10(1):9- 12.

共引文献12

同被引文献29

  • 1杨纯正,刘瑞林,刘建,邵小枫.IH764—3对胶原生物合成中脯氨酰羟化的作用[J].中国医学科学院学报,1993,15(5):364-368. 被引量:4
  • 2王智,姚艳娇,张明昌.三氟拉嗪对体外培养人晶状体上皮细胞增殖作用的实验研究[J].眼视光学杂志,2006,8(3):152-153. 被引量:3
  • 3Hui YN, Wu YQ, Xiao QS, Kirchnot B. Corticosteroids and dau- no-mycin in the prevention of experimental proliferative vitreo- retinopathy induced by macrophages[ J ]. Graefe Arch Clin Exp Ophthalmol, 1993,231 ( 2 ) : 109-113.
  • 4Nakagaya M, Refojo MF, Marin JF, Doi M, Tolentino FL. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy [ J ] Invest Oph- thalmol Vis Sci, 1995,35 ( 12 ) :2388-2395.
  • 5Frenzel EM, Neely KA, Walsh AW, Cameron JD, Gregerson DS. A new model of proliferative vitreoretinopathy [ J ]. Invest Oph- thalmol Vis Sci, 1998,39 ( 11 ) :2157-2164.
  • 6Ozerdem U, Mach-Hofacre B, Keefe K, Pham T, Souls K, Appelt K, et al. The effect of prinomastat (AG3340), a synthetic inhibi- tor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy[ J ]. Ophthalmic Res,2001,33( 1 ) :20-23.
  • 7Wagner M,Benson MT,Rennie IG,Mac Neff S. Effects of phar- macological modulation of intracellular signalling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins[ J]. Cur Eye Res,1995,14(5) :373-384.
  • 8Craiu AM. Proliferative retinopathy, friend or foe [ J ] ? Oftalmo- logia,2009,53 ( 3 ) :64-72.
  • 9Sadaka A, Giuliari GP. Proliferative vitreoretinopathy: current and emerging treatments [ J ]. Clin Ophthalmol, 2012,6 : 1325- 1333.
  • 10Dewey S. Posterior capsular opacification [ J ]. Curr Opin Oph- thalmol,2005,17 ( 1 ) :45-53.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部